Legacy App users can now access the Health Portal – just reset your password using email as username.

Are Smaller Testosterone Injections Better?

Are Smaller Testosterone Injections Better?

Viewing This Video Is A Member Exclusive Feature

But you don’t need membership to get Dr. O’Connor’s insight on this topic, it’s in the summary, key takeaways, and related drugs and conditions below.

Want to watch the full video? Join the Health Portal Today.

Join Now

Timeline

Timestamp
Topic
00:00
Dr. O’Connor addresses whether scientific studies or academic journals support breaking testosterone injections into smaller doses. He says research exists involving microdosing in women but that he did not find comparable evidence establishing the benefit in men.
01:35
Dr. O’Connor shifts from the lack of direct research to the pharmacokinetic reasoning for fractional testosterone dosing. He discusses avoiding a large bolus, reducing peaks and troughs, and choosing practical injection schedules based on testosterone ester half-life.
02:59
Dr. O’Connor returns to the lack of direct supporting data and explains how men can discuss fractional dosing with their doctors. He focuses on the kinetics of smaller doses and considers whether larger peaks and troughs may contribute to estrogen fluctuations and changes in mood.

Video Summary

Smaller testosterone injections are widely discussed, but what does the research actually show for men on TRT. Dr. O’Connor addresses a question about whether scientific studies or academic journals support breaking testosterone injections into smaller doses. He says he found some research involving microdosing in women but did not find comparable evidence for men.

Dr. O’Connor explains that testosterone ester half-lives and drug kinetics provide a rationale for considering smaller, more frequent injections. He discusses how metabolism can vary between individuals based on biochemistry, other medications, health factors, and even smoking, making the response to a particular dosing schedule individual.

Although he says direct research supporting smaller fractional doses in men is lacking, Dr. O’Connor discusses avoiding a large bolus injection and instead dividing testosterone into smaller doses. He describes several schedules men use, including every five days, alternating every three to four days, and other more frequent approaches, while noting that daily or every-other-day injections may add unnecessary work.

Dr. O’Connor also discusses using a small insulin syringe and says injections can be administered subcutaneously or intramuscularly. He returns to the pharmacokinetic rationale for fractional dosing, focusing on testosterone half-life and reducing peaks and troughs rather than claiming that clinical studies have established a benefit.

He encourages men to discuss the reasoning with their doctors while acknowledging the absence of direct supporting data in men. The discussion also considers whether larger fluctuations could affect estrogen and contribute to changes in mood.

Drug Callouts

Drug
Description
Testosterone
Testosterone is discussed in relation to injection frequency, ester half-life, and dividing larger injections into smaller fractional doses. Dr. O’Connor says direct research demonstrating the benefit of this approach in men is lacking and instead discusses the pharmacokinetic rationale involving peaks and troughs.
Testosterone Propionate
Testosterone propionate is mentioned while Dr. O’Connor compares the half-lives of different testosterone esters. Its shorter half-life is part of his discussion of how ester selection and injection timing affect testosterone kinetics.
Testosterone Enanthate
Testosterone enanthate is discussed as a longer-acting testosterone ester when comparing half-lives and dosing frequency. Dr. O’Connor uses ester half-life as part of his explanation for dividing testosterone into smaller injections.
Testosterone Cypionate
Testosterone cypionate is mentioned among the longer-acting testosterone esters discussed in the video. Dr. O’Connor considers its kinetics when explaining the rationale for smaller fractional injections rather than a larger bolus dose.
Sustanon
Sustanon is discussed as a multi-ester testosterone preparation while Dr. O’Connor reviews testosterone half-lives and injection schedules. It is included in his broader discussion of dividing testosterone doses to reduce peaks and troughs.

Condition Callouts

Condition
Description
Mood Changes
Mood changes are discussed as a possible consequence of larger fluctuations in testosterone levels. Dr. O’Connor raises the possibility that pronounced peaks and troughs could contribute to anger or depression in some men.

Key Takeaways

  • Dr. O’Connor says direct research demonstrating the benefits of smaller fractional testosterone injections in men is lacking.
  • Testosterone ester half-life and individual drug metabolism influence how hormone levels change between injections.
  • Dr. O’Connor uses pharmacokinetics and the goal of reducing peaks and troughs to explain the rationale for fractional dosing.
  • Several testosterone injection schedules can divide a dose, while very frequent injections may become unnecessarily burdensome.
  • Individual biochemistry, medications, health factors, and smoking can influence drug metabolism and response.
  • Dr. O’Connor encourages discussing smaller testosterone doses with a physician while acknowledging the lack of direct supporting studies in men.